RPGLIFE

RPG Life Sciences Share Price

₹2,121.00 +29.7 (1.42%)

02 May, 2025 09:31

SIP TrendupStart SIP in RPGLIFE

Start SIP

Performance

  • Low
  • ₹2,105
  • High
  • ₹2,160
  • 52 Week Low
  • ₹1,381
  • 52 Week High
  • ₹2,975
  • Open Price₹2,150
  • Previous Close₹2,091
  • Volume5,862

Investment Returns

  • Over 1 Month -6.01%
  • Over 3 Month -14%
  • Over 6 Month -19.09%
  • Over 1 Year + 37.16%
SIP Lightning

Smart Investing Starts Here Start SIP with RPG Life Sciences for Steady Growth!

Invest Now

RPG Life Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 19.1
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 3,508
  • P/B Ratio
  • 9.2
  • Average True Range
  • 135.89
  • EPS
  • 71.51
  • Dividend Yield
  • 0.8
  • MACD Signal
  • -4.37
  • RSI
  • 44.01
  • MFI
  • 82.56

RPG Life Sciences Financials

RPG Life Sciences Technicals

EMA & SMA

Current Price
₹2,121.00
+ 29.7 (1.42%)
pointer
  • stock-down_img
  • Bearish Moving Average 16
  • stock-up_img
  • Bullish Moving Average 0
  • 20 Day
  • ₹2,189.73
  • 50 Day
  • ₹2,207.13
  • 100 Day
  • ₹2,213.63
  • 200 Day
  • ₹2,126.96

Resistance and Support

2133.43 Pivot Speed
  • R3 2,353.87
  • R2 2,294.43
  • R1 2,192.87
  • S1 2,031.87
  • S2 1,972.43
  • S3 1,870.87

What's your outlook on RPG Life Sciences?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

RPG Life Sciences Ltd. is a prominent pharmaceutical company in India, specializing in the development, manufacturing, and marketing of generic formulations, active pharmaceutical ingredients (APIs), and contract research services. The company focuses on quality and innovation across therapeutic segments.

R P G Life Sciences has an operating revenue of Rs. 653.43 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 36% is great, ROE of 34% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 73 which is a FAIR score but needs to improve its earnings, a RS Rating of 67 which is FAIR indicating the recent price performance, Buyer Demand at D which indicates heavy supply, Group Rank of 75 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock definitely has some strength, you may want to examine it in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

RPG Life Sciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-04-28 Audited Results & Final Dividend
2025-01-24 Quarterly Results
2024-11-07 Quarterly Results
2024-07-19 Quarterly Results
2024-04-30 Audited Results & Final Dividend
Date Purpose Remarks
2024-06-28 FINAL Rs.16.00 per share(200%)Final Dividend
2023-07-21 FINAL Rs.12.00 per share(150%)Final Dividend
2022-07-15 FINAL Rs.9.60 per share(120%)Final Dividend
2021-08-17 FINAL Rs.7.20 per share(90%)Dividend
View More

RPG Life Sciences F&O

RPG Life Sciences Shareholding Pattern

72.95%
3.53%
0.21%
1.46%
0.01%
15.33%
6.51%

About RPG Life Sciences

  • NSE Symbol
  • RPGLIFE
  • BSE Symbol
  • 532983
  • Managing Director
  • Mr. Yugal Sikri
  • ISIN
  • INE105J01010

Similar Stocks to RPG Life Sciences

RPG Life Sciences FAQs

RPG Life Sciences share price is ₹2,121 As on 02 May, 2025 | 09:17

The Market Cap of RPG Life Sciences is ₹3507.9 Cr As on 02 May, 2025 | 09:17

The P/E ratio of RPG Life Sciences is 19.1 As on 02 May, 2025 | 09:17

The PB ratio of RPG Life Sciences is 9.2 As on 02 May, 2025 | 09:17

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23